Sharma A, Tyagi P, Khumallambam M, Tyagi M
Cells. 2024; 13(23).
PMID: 39682697
PMC: 11640508.
DOI: 10.3390/cells13231950.
Sharma A, Tyagi P, Khumallambam M, Tyagi M
bioRxiv. 2024; .
PMID: 39229050
PMC: 11370412.
DOI: 10.1101/2024.08.19.608673.
Liu Y, Zhu J, Zhou S, Hou Y, Yan Z, Ao X
MedComm (2020). 2024; 5(8):e690.
PMID: 39135916
PMC: 11318340.
DOI: 10.1002/mco2.690.
Camfield S, Chakraborty S, Dwivedi S, Pramanik P, Mukherjee P, Bhattacharya R
NPJ Precis Oncol. 2024; 8(1):154.
PMID: 39043779
PMC: 11266574.
DOI: 10.1038/s41698-024-00655-1.
Buehl C, Goff N, Mikhova M, Hardwick S, Blundell T, Modesti M
Res Sq. 2024; .
PMID: 38168382
PMC: 10760257.
DOI: 10.21203/rs.3.rs-3627471/v1.
Fibrillarin promotes homologous recombination repair by facilitating the recruitment of recombinase RAD51 to DNA damage sites.
Mu Y, Han J, Wu M, Li Z, Du K, Wei Y
J Zhejiang Univ Sci B. 2023; 24(12):1165-1173.
PMID: 38057273
PMC: 10710916.
DOI: 10.1631/jzus.B2300518.
Therapeutic Targeting of DNA Replication Stress in Cancer.
Gu L, Hickey R, Malkas L
Genes (Basel). 2023; 14(7).
PMID: 37510250
PMC: 10378776.
DOI: 10.3390/genes14071346.
Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes.
Li L, Jiang D, Liu H, Guo C, Zhao R, Zhang Q
Nat Commun. 2023; 14(1):1751.
PMID: 36991000
PMC: 10060430.
DOI: 10.1038/s41467-023-37221-5.
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.
Matsumoto Y
Int J Mol Sci. 2022; 23(8).
PMID: 35457081
PMC: 9032228.
DOI: 10.3390/ijms23084264.
SENP3-mediated TIP60 deSUMOylation is required for DNA-PKcs activity and DNA damage repair.
Han Y, Huang X, Cao X, Li Y, Gao L, Jia J
MedComm (2020). 2022; 3(2):e123.
PMID: 35356800
PMC: 8941250.
DOI: 10.1002/mco2.123.
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer.
Dylgjeri E, Kothari V, Shafi A, Semenova G, Gallagher P, Guan Y
Clin Cancer Res. 2022; 28(7):1446-1459.
PMID: 35078861
PMC: 9365345.
DOI: 10.1158/1078-0432.CCR-21-1846.
Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
Ye Z, Shi Y, Lees-Miller S, Tainer J
Front Immunol. 2021; 12:797880.
PMID: 34970273
PMC: 8712645.
DOI: 10.3389/fimmu.2021.797880.
DNA-PKcs: A Targetable Protumorigenic Protein Kinase.
Dylgjeri E, Knudsen K
Cancer Res. 2021; 82(4):523-533.
PMID: 34893509
PMC: 9306356.
DOI: 10.1158/0008-5472.CAN-21-1756.
Structural insights into the role of DNA-PK as a master regulator in NHEJ.
Chen S, Lees-Miller J, He Y, Lees-Miller S
Genome Instab Dis. 2021; 2(4):195-210.
PMID: 34723130
PMC: 8549938.
DOI: 10.1007/s42764-021-00047-w.
Drug Repurposing for Targeting Acute Leukemia With ()-Gene Rearrangements.
Tsakaneli A, Williams O
Front Pharmacol. 2021; 12:741413.
PMID: 34594227
PMC: 8478155.
DOI: 10.3389/fphar.2021.741413.
DNA-Dependent Protein Kinase Catalytic Subunit: The Sensor for DNA Double-Strand Breaks Structurally and Functionally Related to Ataxia Telangiectasia Mutated.
Matsumoto Y, Asa A, Modak C, Shimada M
Genes (Basel). 2021; 12(8).
PMID: 34440313
PMC: 8394720.
DOI: 10.3390/genes12081143.
Cryo-EM of NHEJ supercomplexes provides insights into DNA repair.
Chaplin A, Hardwick S, Kefala Stavridi A, Buehl C, Goff N, Ropars V
Mol Cell. 2021; 81(16):3400-3409.e3.
PMID: 34352203
PMC: 9006396.
DOI: 10.1016/j.molcel.2021.07.005.
Nonhomologous DNA end joining of nucleosomal substrates in a purified system.
Gerodimos C, Watanabe G, Lieber M
DNA Repair (Amst). 2021; 106:103193.
PMID: 34339948
PMC: 8435023.
DOI: 10.1016/j.dnarep.2021.103193.
Genomic Correlates of DNA Damage in Breast Cancer Subtypes.
Morafraile E, Perez-Pena J, Fuentes-Antras J, Manzano A, Perez-Segura P, Pandiella A
Cancers (Basel). 2021; 13(9).
PMID: 33925616
PMC: 8123819.
DOI: 10.3390/cancers13092117.
The emerging relationship between metabolism and DNA repair.
Cucchi D, Gibson A, Martin S
Cell Cycle. 2021; 20(10):943-959.
PMID: 33874857
PMC: 8172156.
DOI: 10.1080/15384101.2021.1912889.